HER2 amplification levels were analogous in different PD‐L1 CPS subgroups (p = 0.339, Figure 1D), indicating independent predictive value of HER2 amplification and PD‐L1 CPS in GC. This evidence concerns the gene ERBB2 and gastric cancer.